Medicine News and Research

RSS

Military physicians will soon pick up joysticks to save lives of children

Military physicians will soon pick up joysticks instead of textbooks to learn skills that could save lives of children with serious health threats.

7 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).

7 Jul 2014

Higher socioeconomic status associated with higher rates of hookah use

While cigarette use is declining precipitously among youth, evidence indicates that American adolescents are turning to ethnically-linked alternative tobacco products, such as hookahs, cigars, and various smokeless tobacco products, according to a recent report from the Centers for Disease Control and Prevention.

7 Jul 2014

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.

7 Jul 2014

First Edition: July 7, 2014

Today's headlines include a range of stories related to the implementation of the health law, and the politics surrounding it.

7 Jul 2014

Treating ulcerative colitis and Crohn’s disease

Ulcerative colitis and Crohn’s disease are idiopathic (we don’t know the cause) inflammatory diseases (IBD) of the colon and/or small bowel. They are chronic in that we do not have a medical cure and are differentiated from IBS (irritable bowel syndrome) by inflammation that causes ulcerations of the GI tract.

7 Jul 2014

Findings shed light on possible role of affective temperaments in cardiovascular morbidity

Temperament has been traditionally associated with high blood pressure. A new study that has appeared in the current issue of Psychotherapy and Psychosomatics has substantiated this issue.

7 Jul 2014

Global toolkit for managing menopause

Created at Monash University, the world's first toolkit is designed for GPs to use with women from the age of 40. Thought to be the first of its kind, researchers say the toolkit has the potential to help manage menopausal conditions for women globally.

7 Jul 2014

Standard risk factors stratify already high-risk diabetic patients

Cardiovascular disease risk factors are associated with mortality even among patients with Type 2 diabetes who are already at high risk due to having high coronary artery calcified plaque, say researchers.

4 Jul 2014

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

It has been known for its flavorful addition to soups and as a delicacy for dogs but bone marrow fat may also have untapped health benefits, new research finds.

4 Jul 2014

OHSU professor recognized with AAAS Martin and Rose Wachtel Cancer Research Award

Jeffrey Tyner, Ph.D., assistant professor of Cell, Developmental & Cancer Biology for Oregon Health & Science University (OHSU) and a researcher with OHSU's Knight Cancer Institute, has won a distinguished award from the American Association for the Advancement of Science (AAAS) for the development of a research program that more rapidly identifies the mutations driving a patient's cancer and accelerates development of precision treatments.

4 Jul 2014

Medicine News and Research

Military physicians will soon pick up joysticks to save lives of children

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

Higher socioeconomic status associated with higher rates of hookah use

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

First Edition: July 7, 2014

Treating ulcerative colitis and Crohn’s disease

Findings shed light on possible role of affective temperaments in cardiovascular morbidity

Global toolkit for managing menopause

Standard risk factors stratify already high-risk diabetic patients

High level of adiponectin linked to decreased risk of diabetes, cardiovascular disease

OHSU professor recognized with AAAS Martin and Rose Wachtel Cancer Research Award

DFG to establish five new Research Units to pursue current issues in research areas

Transcription factor IRF4 plays key role in brown fat's thermogenic process

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

Plasmonic biosensors: A key asset in personalised medicine

Researchers discover mechanical threshold that regulates angiogenesis

Study shows how psychedelic drug alters brain activity to produce unusual psychological effects

Orthopedic surgeon offers critical insights on total knee replacement surgery

Researchers identify pathogenic mechanism common to several neurodegenerative diseases

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News